UPDATE: Bicycle Therapeutics (BCYC) PT Raised to $65 at Roth Capital on Initial Success of EphA2 Targeting Platform
Tweet Send to a Friend
(Updated - October 8, 2021 6:16 AM EDT)
Roth Capital analyst Tony Butler raised the price target on Bicycle ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Roth Capital analyst Tony Butler raised the price target on Bicycle ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
